Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance
Mar 12, 2020 - Business Wire
Board and Executive Moves-Financial Results
Regulatory News:
Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded its raised guidance for full-year 2019 on both net sales and EBITDA.
FINANCIAL PERFORMANCE: STRONG SALES AND PROFIT GROWTH CONTINUES
•
Net sales of CHF 1,887.2 million, up 18.5%
•
EBITDA of CHF 540.0 million, up 37.9%
•
Core EPS of C...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
